121 related articles for article (PubMed ID: 1106842)
1. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
[TBL] [Abstract][Full Text] [Related]
2. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)].
Mutz ID; Urban CE
Wien Klin Wochenschr; 1978 Dec; 90(24):867-70. PubMed ID: 741754
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors.
Cangir A; Morgan SK; Land VJ; Pullen J; Starling SA; Nitschke R
Med Pediatr Oncol; 1976; 2(2):183-90. PubMed ID: 958160
[TBL] [Abstract][Full Text] [Related]
4. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
[TBL] [Abstract][Full Text] [Related]
5. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of solid tumors in children.
Finklestein JZ; Albo V; Ertel I; Hammond D
Cancer Chemother Rep; 1975; 59(2 Pt 1):351-7. PubMed ID: 167936
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies with DTIC (NSC-45388) in various malignancies.
Slavik M
Cancer Treat Rep; 1976 Feb; 60(2):213-4. PubMed ID: 769976
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide, adriamycin, and DTIC polychemotherapy in advanced small cell lung cancer.
Saiontz HI; Dalton RJ; Eagan RT
Cancer Treat Rep; 1977; 61(3):481-3. PubMed ID: 194692
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
[TBL] [Abstract][Full Text] [Related]
9. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.
Azizi F; Bitran J; Javehari G; Herbst AL
Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy in disseminated melanoma and other solid tumors in adults.
Gerner RE; Moore GE; Dickey C
Oncology; 1975; 31(1):22-30. PubMed ID: 1099501
[TBL] [Abstract][Full Text] [Related]
11. DTIC (NSC-45388) in malignant melanoma: a perspective.
Comis RL
Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
[No Abstract] [Full Text] [Related]
12. DTIC (NSC-45388) studies in the southwest oncology group.
Costanzi JJ
Cancer Treat Rep; 1976 Feb; 60(2):189-92. PubMed ID: 769972
[TBL] [Abstract][Full Text] [Related]
13. Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441).
Taylor SG; Nelson L; Baxter D; Rosenbaum C; Sponzo RW; Cunningham TJ; Olson KB; Horton J
Cancer; 1975 Oct; 36(4):1269-76. PubMed ID: 169984
[TBL] [Abstract][Full Text] [Related]
14. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
[TBL] [Abstract][Full Text] [Related]
15. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
[TBL] [Abstract][Full Text] [Related]
16. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
17. High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy.
Smith PJ; Ekert H; Waters Kd; Matthews RN
Cancer Treat Rep; 1977 Dec; 61(9):1736-8. PubMed ID: 597823
[No Abstract] [Full Text] [Related]
18. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
[No Abstract] [Full Text] [Related]
19. [Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma].
Abele R; Alberto P; Germano G; Obrecht JP; Wagenknecht L
Schweiz Med Wochenschr; 1976 Jul; 106(28):961-3. PubMed ID: 63145
[TBL] [Abstract][Full Text] [Related]
20. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
Gasparini M; Bellani FF; Musumeci R; Bonadonna G
Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
